Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Aethlon Medical, Inc. (AEMD)

0.6193   -0.041 (-6.17%) 02-03 15:18
Open: 0.6606 Pre. Close: 0.66
High: 0.6899 Low: 0.5901
Volume: 594,740 Market Cap: 14(M)

Technical analysis

as of: 2023-02-03 3:15:07 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.01     One year: 1.18
Support: Support1: 0.48    Support2: 0.25
Resistance: Resistance1: 0.87    Resistance2: 1.01
Pivot: 0.52
Moving Average: MA(5): 0.64     MA(20): 0.5
MA(100): 0.5     MA(250): 0.93
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 53.4     %D(3): 52.1
RSI: RSI(14): 62.1
52-week: High: 2.46  Low: 0.23
Average Vol(K): 3-Month: 1,027 (K)  10-Days: 4,760 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ AEMD ] has closed below upper band by 23.8%. Bollinger Bands are 52.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.72 - 0.72 0.72 - 0.73
Low: 0.65 - 0.65 0.65 - 0.65
Close: 0.65 - 0.66 0.66 - 0.66

Company Description

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Headline News

Tue, 31 Jan 2023
Is Aethlon Medical, Inc. (AEMD) a Good Buy in the Medical Devices Industry? - InvestorsObserver

Tue, 31 Jan 2023
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and ... - InvestorPlace

Mon, 30 Jan 2023
Why Is Aethlon Medical (AEMD) Stock Up 50% Today? - InvestorPlace

Mon, 30 Jan 2023
Thinking about buying stock in Exela Technologies, Genius Group ... - PR Newswire

Mon, 30 Jan 2023
Aethlon Medical (AEMD) Announces Contract with NAMSA to ... - StreetInsider.com

Fri, 06 Jan 2023
Why Spruce Biosciences Shares Are Trading Higher By 100 ... - Investing.com UK

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 0 (M)
Shares Float 23 (M)
% Held by Insiders 2.278e+007 (%)
% Held by Institutions 1 (%)
Shares Short 302 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -1.276e+007
EPS Est Next Qtl 0
EPS Est This Year -0.5
EPS Est Next Year -2
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -42
Return on Assets (ttm) 624.5
Return on Equity (ttm) -34.4
Qtrly Rev. Growth 30230
Gross Profit (p.s.) 0
Sales Per Share -68.47
EBITDA (p.s.) 330528
Qtrly Earnings Growth -0.7
Operating Cash Flow 0 (M)
Levered Free Cash Flow -11 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 0.63

Stock Dividends

Dividend 0
Forward Dividend 209890
Dividend Yield 0%
Dividend Pay Date 2019-10-14
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.